Publikationen, an denen er mitarbeitet Javier Benítez Ortiz (13)

2022

  1. OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells

    Frontiers in Oncology, Vol. 12

2021

  1. Alterations in slc4a2, slc26a7 and slc26a9 drive acid–base imbalance in gastric neuroendocrine tumors and uncover a novel mechanism for a co-occurring polyautoimmune scenario

    Cells, Vol. 10, Núm. 12

  2. Small molecule inhibitor of OGG1 blocks oxidative DNA damage repair at telomeres and potentiates methotrexate anticancer effects

    Scientific Reports, Vol. 11, Núm. 1

  3. Targeting OGG1 arrests cancer cell proliferation by inducing replication stress

    Nucleic Acids Research, Vol. 48, Núm. 21, pp. 12234-12251

2015

  1. A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families

    Nature Communications, Vol. 6

2005

  1. A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma

    Genes Chromosomes and Cancer, Vol. 42, Núm. 3, pp. 260-268

  2. About the origin and development of hereditary conventional renal cell carcinoma in a four-generation t(3;8) (p14.1;q24.23) family

    European Journal of Human Genetics, Vol. 13, Núm. 5, pp. 570-578

2004

  1. Cloning of a new familial t(3;8) translocation associated with conventional renal cell carcinoma reveals a 5 kb microdeletion and no gene involved in the rearrangement

    Human Molecular Genetics, Vol. 13, Núm. 9, pp. 983-990

  2. Molecular cytogenetic characterization of rhabdomyosarcoma cell lines

    Cancer Genetics and Cytogenetics, Vol. 148, Núm. 1, pp. 35-43

  3. Simultaneous detection of the immunophenotypic markers and genetic aberrations on routinely processed paraffin sections of lymphoma samples by means of the FICTION technique

    Leukemia, Vol. 18, Núm. 2, pp. 348-353

2003

  1. Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques

    Cancer Genetics and Cytogenetics, Vol. 141, Núm. 2, pp. 138-142

  2. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1)

    Human Genetics, Vol. 112, Núm. 2, pp. 178-185

2002

  1. Cytogenetic characterization reveals that the SAM-1 erythroid cell line is derived from K-562 cells [4]

    Blood